Search
for
Sort by
Research 301–330 of 1000+
- Regulatory T Cells: the Many Faces of Foxp3
- Neuroendocrinology of the hair follicle: principles and clinical perspectives
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Biomembrane-Based Nanostructure- and Microstructure-Loaded Hydrogels for Promoting Chronic Wound Healing
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going
- SEXUAL DIMORPHISM IN MAMMALS
- Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models
- Circulating androgen regulation by androgen-catabolizing gut bacteria in male mouse gut
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Stimulation of elastin expression by minoxidil in chick skin fibroblasts
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- Testosterone: The Male Sex Hormone
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight
- Body Composition Parameters, Carotid Intima Media Thickness and Epicardial Fat Thickness in Male Patients with Androgenetic Alopecia
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Idiopathic Hirsutism*
- Adverse health effects of androgen use
- Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- The involvement of androgens in human hair growth
- Physiological perspective of Hirsutism in Unani Medicine: An Overview and Update
- Understanding Polycystic Ovary Syndrome
- Sex hormones and related compounds, including hormonal contraceptives
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty